News

2017

 

Dezember 2017:

  • Der Immunologe Prof. Veit Hornung klärt zentrale Abwehrmechanismen des angeborenen Immunsystems auf. Jetzt bekommt er für seine Arbeiten den wichtigsten deutschen Forschungspreis: den Leibniz-Preis 2017 der Deutschen Forschungsgemeinschaft. Veit Hornung hat in der Abteilung für Klinische Pharmakologie promoviert und war Postdoktorand in der Abteilung (DE/SZ.de)

November 2017:

  • Our manuscript on the regulation of Interleukin-22 in cancer was released in PNAS! Congratulations to Cornelia, Peter, Adrian and Ana for the huge efforts that went into this manuscript! (DE)

           PNAS_Nov2017


Oktober 2017:

  • Prof. Dr. Simon Rothenfusser: Gemeinsamer Projektantrag mit Anne Krug (LMU) und Giovanna Barba-Späeth (Institut Pasteur, Paris) im Rahmen der ANR-DFG Cooperation 2017 in Natural, Life and Engineering Sciences bewilligt
  • Dr. Felicitas Rataj has been awarded a 2-year fellowship from Peter-and-Traudl-Engelhorn Foundation

August 2017:

  • Dr. Lars König: Antrag auf Projektförderung bei der Else Kröner Fresenius-Stiftung in Höhe von 297.973 Euro wurde bewilligt
  • PD Dr. Sebastian Kobold mit ERC Starting Grant ausgezeichnet (DE)

Juli 2017:

  • On July 7th the Division welcomed as a guest Prof. Jules Hoffmann, Université de Strasbourg. Prof. Hoffmann is a world leader in innate immunity. He received the Nobel Prize in Physiology and Medicine in 2011 for his discovery of the toll system in insects.

           Jules_Hoffmann


May 2017:

  • PD Dr. Sebastian Kobold und Prof. Dr. Stefan Endres: Antrag Onkattract beim Bundesministerium für Bildung und Forschung, Projektträger Jülich wurde mit 1.202.588,40 Euro bewilligt

February 2017:

  • Adrian Gottschlich was selected for the "Studienstiftung des deutschen Volkes"
  • Severin Jacobi was selected for a Jose-Carreras-Foundation doctoral student fellowship
  • Angelina Krächan was selected for a Mildreed-Scheel-Foundation doctoral
    student fellowship
  • PD Dr. Sebastian Kobold was awarded the Hugo-Wilhelm-von Ziemssen-Award
    for medical research

January 2017:

  • PD Dr. Sebastian Kobold and Prof. Dr. Stefan Endres: New research cooperation with TCR2 Therapeutics Inc. located in Cambridge, USA to improve T cell-based therapy (DE/EN)

 

2016

 

October 2016:

  • PD Dr. med. Sebastian Kobold received the Vincenz-Czerny Award 2016 by the German Society for Hematology and Medical Oncology

September 2016:

  • Max Knott and Moritz Schmidbauer were selected into the "MeCuM StEP - Studierende Exzellenz Programm" LMU

August 2016:

  • Cornelia Ochs was awarded funding by the CIPSMwomen program


July 2016:

  • Stefan Stoiber was awarded funding by the LMUexcellent student research program
  • Our manuscript "Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases" was accepted for publication in BMC Cancer, congratulations to Amanda and her team!
  • AG Anz was awarded funding by the Wilhelm-Sander-Stiftung

June 2016:

  • Dr. Felicitas Rataj was awarded funding by the Friedrich Baur Foundation
  • PD Dr. Sebastian Kobold was awarded funding by the LMUExcellent program
  • The Clinician Scientist Program Cancer Immunotherapy (CSP Munich) coordinated by Prof. Marion Subklewe has been selected for funding by the Else Kröner Fresenius Stiftung. PD Dr. Sebastian Kobold is one of the PI of the program. Congratulations!

May 2016:

  • Our manuscript "A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice" was accepted for publication in Oncoimmunology. Congratulations to Gabi and her team!

April 2016:

  • PD Dr. med. Sebastian Kobold receives the BMS-Melanoma Research Alliance Young Investigator Award

  • PD Dr. med. Sebastian Kobold is awarded funding by the Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der Ludwig-Maximilians-Universität München

  • Fabian Kraus is awarded a travel grant to the CIMT meeting 2016 in Mainz by the Studienstiftung des Deutschen Volkes


March 2016:

  • Dr. Felicitas Rataj is awarded funding from the CIPSM Gender Program

  • Stefanie Lesch is awarded funding from the CIPSM Gender Program

  • Clara Karches is awarded funding from the CIPSM Gender Program


January 2016:

  • PD Dr. Sebastian Kobold is selected for the career advancement award of the Ernst Jung Stiftung